Close
Back to TARS Stock Lookup

(TARS) – Management Comments

Jun 21, 2021 06:04 AM Tarsus Pharmaceuticals (TARS) Announces Positive Results of TP-03 Phase 2b/3 Saturn-1 Trial
Dec 23, 2020 07:03 AM Tarsus Pharmaceuticals (TARS) Announces Type C Meeting with FDA Regarding NDA Submission Requirements for Lead Candidate TP-03

Back to TARS Stock Lookup